LH Laboratory Corp Of America Holdings

Price (delayed)

$228.90

Market cap

$22.29B

P/E Ratio

26.4

Dividend/share

N/A

EPS

$8.67

Enterprise value

$28.31B

Sector: Healthcare
Industry: Diagnostics & Research

Laboratory Corporation of America Holdings, more commonly known as LabCorp, is an American S&P 500 company headquartered in Burlington, North Carolina. It operates one of the largest clinical laboratory networks ...

Highlights

Laboratory Corp Of America Holdings's EPS has surged by 134% QoQ and by 13% YoY
LH's net income has soared by 133% from the previous quarter and by 12% YoY
The price to earnings (P/E) is 26% higher than the 5-year quarterly average of 21.0 but 16% lower than the last 4 quarters average of 31.3

Key stats

What are the main financial stats of LH
Market
Shares outstanding
97.4M
Market cap
$22.29B
Enterprise value
$28.31B
Valuations
Price to earnings (P/E)
26.4
Price to book (P/B)
2.71
Price to sales (P/S)
1.79
EV/EBIT
18.98
EV/EBITDA
12.37
EV/Sales
2.28
Earnings
Revenue
$12.44B
EBIT
$1.49B
EBITDA
$2.29B
Free cash flow
$1.52B
Per share
EPS
$8.67
Free cash flow per share
$15.61
Book value per share
$84.59
Revenue per share
$127.74
TBVPS
$73.98
Balance sheet
Total assets
$18.74B
Total liabilities
$10.48B
Debt
$6.68B
Equity
$8.24B
Working capital
$1.08B
Liquidity
Debt to equity
0.81
Current ratio
1.36
Quick ratio
1.12
Net debt/EBITDA
2.63
Margins
EBITDA margin
18.4%
Gross margin
31.1%
Net margin
6.8%
Operating margin
12%
Efficiency
Return on assets
4.7%
Return on equity
11.2%
Return on invested capital
14.6%
Return on capital employed
9.5%
Return on sales
12%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LH stock price

How has the Laboratory Corp Of America Holdings stock price performed over time
Intraday
0.2%
1 week
2.32%
1 month
12.54%
1 year
27.48%
YTD
12.45%
QTD
12.45%

Financial performance

How have Laboratory Corp Of America Holdings's revenue and profit performed over time
Revenue
$12.44B
Gross profit
$3.87B
Operating income
$1.49B
Net income
$844.9M
Gross margin
31.1%
Net margin
6.8%
LH's net income has soared by 133% from the previous quarter and by 12% YoY
The net margin has surged by 113% since the previous quarter and by 3% year-on-year
Laboratory Corp Of America Holdings's operating income has surged by 91% QoQ and by 14% YoY
The operating margin has soared by 76% from the previous quarter and by 5% YoY

Growth

What is Laboratory Corp Of America Holdings's growth rate over time

Valuation

What is Laboratory Corp Of America Holdings stock price valuation
P/E
26.4
P/B
2.71
P/S
1.79
EV/EBIT
18.98
EV/EBITDA
12.37
EV/Sales
2.28
Laboratory Corp Of America Holdings's EPS has surged by 134% QoQ and by 13% YoY
The price to earnings (P/E) is 26% higher than the 5-year quarterly average of 21.0 but 16% lower than the last 4 quarters average of 31.3
The P/B is 29% higher than the last 4 quarters average of 2.1 and 18% higher than the 5-year quarterly average of 2.3
The company's equity rose by 14% YoY and by 12% QoQ
LH's price to sales (P/S) is 38% higher than its last 4 quarters average of 1.3 and 28% higher than its 5-year quarterly average of 1.4
LH's revenue is up by 9% year-on-year and by 8% since the previous quarter

Efficiency

How efficient is Laboratory Corp Of America Holdings business performance
LH's ROA has soared by 135% QoQ and by 7% YoY
LH's ROE has soared by 124% QoQ and by 6% YoY
The company's return on invested capital has surged by 78% QoQ and by 14% YoY
Laboratory Corp Of America Holdings's return on sales has surged by 64% QoQ and by 8% YoY

Dividends

What is LH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LH.

Financial health

How did Laboratory Corp Of America Holdings financials performed over time
LH's total assets is 79% greater than its total liabilities
The quick ratio has grown by 23% from the previous quarter and by 17% YoY
Laboratory Corp Of America Holdings's current ratio has increased by 21% from the previous quarter and by 16% YoY
The debt is 19% smaller than the equity
LH's debt to equity is down by 21% year-on-year and by 16% since the previous quarter
The company's equity rose by 14% YoY and by 12% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.